Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
ZJYL JIN management prioritizes core medical device segment expansion to drive sustained longterm revenue growth iShares Latin America 40 ETF ILF Outperforms US Benchmarks Amid Regional Policy Tailwinds and Broader Market Volatility What Talos Energy TALO is doing that changes everything In Focus 20260511 ON ON shares rise 239 percent post Q4 2025 earnings despite slight EPS miss and 153 percent yearoveryear revenue drop QLYS Qualys posts Q4 2025 earnings beat and 101 percent yearoveryear revenue growth as shares rise 282 percent JPMorgan Chase Co JPM Raises Halma LSEHLMA Price Target Amid Nuanced Valuation Reassessment State Street SPDR SP Software Services ETF XSW 2026 Investment Profile and RiskReturn Assessment for US Software Sector Exposure What DHI Group DHX does that its rivals cannot On the Radar 20260505 ECAT BlackRock shares updated ESG capital allocation plans alongside its latest quarterly earnings results UniFuels UFG Stock Today Drops 260 Key Support at 071 20260518 Nicolet Bankshares NIC Gains 267 Support Holds at 13380 20260518 MettlerToledo International MTD Stock Analysis 224 Loss Key Levels 20260519 Jim Cramer Highlights Positive Development for Cisco CSCO Amid Networking Demand Yardeni Warns of Potential July Rate Hike as Bond Vigilantes Target Incoming Fed Chair Warsh Starry Sea SSEA Stock Analysis RangeBound Near 1017 20260521 Array Tech ARRY Q1 2026 Earnings Surge EPS 006 vs 005 Forecast Aluminum Price Surge Pressures Major US Companies Amid Iran Conflict CPK Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Lower IP Q1 2026 Earnings Modest EPS Beat Supports Positive Sentiment PMTV Q1 2026 Earnings Trust Reports Significant EPS Miss Amidst Challenging Mortgage Environment CRNC Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Uptick EQX Q1 2026 Earnings Marginal EPS Miss as Stock Declines Tarsus Pharmaceuticals TARS Faces Resistance at 63 Pulls Back to 60 Support Zone Nano Labs Ltd Slips 342 as Stock Approaches Key Support Level Enterprise Products Partners EPD Slips 278 Key Support and Resistance Levels in Focus CorMedix CRMD Rises 242 as Momentum Builds Toward Key Resistance